Following IPO, Fluidigm Reports Double-Digit Revenue Growth for Q4, FY'10

The company reported a 36 percent increase in fourth-quarter revenues and 32 percent increase in yearly revenues; and CEO Gajus Worthington provided an update regarding the uptake of Fludigm's newest instruments and the company's fledgling diagnostics play.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories